NXSCF

Next Science Limited NXSCF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NXSCF EOFBF CNTMF WOWU ELXMF CWBHF HSTI PVCT MEDIF AHGIF
6M 243.35 % 0.00 % 13.33 % 0.00 % -98.10 % 200.75 % 25.00 % -13.56 % -10.84 % 0.00 %
YTD 14.29 % -66.67 % -33.17 % -99.26 % -98.10 % 177.23 % 400.00 % -46.26 % 27.61 % 0.00 %
1Y 152.37 % -93.33 % -22.29 % -99.26 % -98.10 % 172.11 % 400.00 % -47.78 % 30.37 % 0.00 %
3Y -82.14 % -99.23 % -58.15 % -99.94 % -98.54 % -45.12 % -16.67 % -46.31 % 5.44 % 0.00 %
5Y -91.24 % -99.93 % -89.17 % -99.78 % -99.36 % -92.78 % -69.29 % 11.55 % -85.97 % -99.55 %
10Y -91.24 % -99.93 % -96.94 % -99.80 % -99.24 % -97.83 % 177.78 % -84.22 % -96.81 % -100.00 %
From the beginning -91.24 % -99.93 % -96.94 % -100.00 % -98.64 % -97.83 % 212.50 % -100.00 % -96.81 % -100.00 %

Dividend

Nova Eye Medical Limited